TLX101 therapy was efficacious in recurrent high-grade glioma, a type of brain cancer, according to preliminary results from ...

The Brain Prize 2025 went to neuro-oncologists Michelle Monje and Frank Winkler for pioneering the field of cancer n.

DelveInsight’s, “Glioma Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Glioma pipeline landscape. It covers the Glioma pipeline drug ...

Magnetism offers extremely promising perspectives in biology, particularly in mechanobiology and for various biomedical ...

Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment and enhancing their ability to infiltrate solid tumours.

A phase 2a clinical trial of NEO100-01 is continuing to recruit patients with malignant gliomas, with full enrollment ...

Mar. 13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States ...

The quest for more effective cancer radiotherapy continues apace, with Telix Pharmaceuticals (ASX:TLX) today reporting “encouraging” preliminary results from its phase II study to treat recurrent high ...

The efficacy of vorasidenib in higher-grade gliomas, its role in maintenance therapy ... (A) Normal blood-brain barrier with tight junctions, pericyte cells, astrocyte endfeet, and efflux pumps ...

"There's stem cell enrichment, new blood vessel formation ... A clinically relevant model and method to study necrosis as a driving force in glioma restructuring and progression, Proceedings ...